keyword
MENU ▼
Read by QxMD icon Read
search

Atopic dermatitis and therapy and remission

keyword
https://www.readbyqxmd.com/read/29675335/sub-clinical-assessment-of-atopic-dermatitis-severity-using-angiographic-optical-coherence-tomography
#1
Robert A Byers, Raman Maiti, Simon G Danby, Elaine J Pang, Bethany Mitchell, Matt J Carré, Roger Lewis, Michael J Cork, Stephen J Matcher
Measurement of sub-clinical atopic dermatitis (AD) is important for determining how long therapies should be continued after clinical clearance of visible AD lesions. An important biomarker of sub-clinical AD is epidermal hypertrophy, the structural measures of which often make optical coherence tomography (OCT) challenging due to the lack of a clearly delineated dermal-epidermal junction in AD patients. Alternatively, angiographic OCT measurements of vascular depth and morphology may represent a robust biomarker for quantifying the severity of clinical and sub-clinical AD...
April 1, 2018: Biomedical Optics Express
https://www.readbyqxmd.com/read/29419920/the-regular-use-of-an-emollient-improves-symptoms-of-atopic-dermatitis-in-children-a-randomized-controlled-study
#2
G S Tiplica, F Boralevi, P Konno, L Malinauskiene, A Kaszuba, C Laurens, M Saint-Aroman, A Delarue
BACKGROUND: Emollients are considered as a first-line therapy for the treatment of atopic dermatitis (AD). However, evidence-based proof that the regular use of emollients reduces AD severity is lacking. OBJECTIVE: To assess whether the regular use of emollients results in a reduction in AD severity in children with AD. METHODS: In this multicentre randomized, parallel group, open-label study, children with mild-to-moderate AD were recruited during a flare...
February 8, 2018: Journal of the European Academy of Dermatology and Venereology: JEADV
https://www.readbyqxmd.com/read/29364435/narrowband-uv-b-phototherapy-in-childhood-atopic-dermatitis-efficacy-and-safety
#3
Surabhi Dayal, Kalpana Pathak, Priyadarshini Sahu, Vijay Kumar Jain
BACKGROUND: Narrow-band UVB is the most innovative steroid sparing treatment in atopic dermatitis. There are studies showing efficacy of Narrow-band UVB in childhood atopic dermatitis, but there is lack of clinical trials in the literature determining the length of remission. Therefore, we sought to highlight its efficacy, safety and its post-treatment efficacy in childhood atopic dermatitis. OBJECTIVE: To assess the clinical efficacy, safety of Narrow-band UVB in the treatment of paediatric atopic dermatitis and length of remission during 2 years of post-treatment follow-up...
November 2017: Anais Brasileiros de Dermatologia
https://www.readbyqxmd.com/read/29249110/-severe-atopic-dermatitis-and-hiper-ige
#4
María Luz Cid Del Prado-Izquierdo, Osvaldo Zarco-Cid Del Prado, Ángel Visoso-Salgado
BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory and complex skin disease, typically occurring in individuals with a personal or family history of atopy. It is characterized by lesions of dermatitis, pruritus and dry skin (xerosis) that evolve with chronic course and intermittent outbreaks alternating with remission phases. AD appears from 5-15 % of the general population, 10-20 % of the pediatric population, and 1-3 % of the adult population. CLINICAL REPORT: A 19-year-old male patient with a severe AD (SCORAD of 84...
October 2017: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://www.readbyqxmd.com/read/29134748/novel-topical-agent-containing-superoxide-dismutase-100%C3%A2-000%C3%A2-iu-and-4-of-plant-extracts-as-a-mono-therapy-for-atopic-dermatitis
#5
Dimitrios Sgouros, Alexander Katoulis, Dimitrios Rigopoulos
INTRODUCTION: Corticosteroids are the mainstay of treatment for the acute phase of atopic dermatitis (AD), whereas topical emollients are mainly used for maintenance of remission. A topical agent that combines emollient and anti-inflammatory properties would achieve control of all phases of AD, without the need for chronic corticosteroid use. AIM: To assess the efficacy of a novel topical agent containing superoxide dismutase (SOD) 100 000 IU and 4% of a combination of plant extracts (blackcurrant seed oil, sunflower oil concentrate, balloon vine extract)...
November 13, 2017: Journal of Cosmetic Dermatology
https://www.readbyqxmd.com/read/28331140/management-of-atopic-dermatitis-in-japan
#6
REVIEW
Hidehisa Saeki
The guidelines for the treatment of atopic dermatitis (AD) issued by the Japanese Dermatological Association (JDA), which are basically designed for dermatologists, were first prepared in 2000 and revised in 2016. The guidelines for AD of the Japanese Society of Allergology (JSA), which are basically designed for allergologists, including internists, otorhinolaryngologists, ophthalmologists, and dermatologists, were first prepared in 2009 and revised in 2014. In this article, I review the definition, pathophysiology, etiology, epidemiology, diagnosis, severity classification, examination for diagnosis and severity assessment, and treatments for AD in Japan according to these two guidelines for AD (JDA and JSA)...
2017: Journal of Nippon Medical School, Nippon Ika Daigaku Zasshi
https://www.readbyqxmd.com/read/28271540/prevention-of-flares-in-children-with-atopic-dermatitis-with-regular-use-of-an-emollient-containing-glycerol-and-paraffin-a-randomized-controlled-study
#7
George Sorin Tiplica, Andrzej Kaszuba, Laura Malinauskienė, Pille Konno, Franck Boralevi, Eric Garrigue, Markéta Saint-Aroman, Alain Delarue
BACKGROUND/OBJECTIVES: Emollients are part of the standard treatment for atopic dermatitis (AD), although there is limited evidence that regular use of emollients as management therapy reduces the frequency of flares and corticosteroid consumption. The objective of this study was to evaluate the benefit of emollient use in the management of mild to moderate AD in children by assessing the ability of two different emollients (particularly V0034CR) to prevent flares and to reduce the use of corticosteroids...
May 2017: Pediatric Dermatology
https://www.readbyqxmd.com/read/27896861/cyclosporine-a-for-severe-atopic-dermatitis-in-children-efficacy-and-safety-in-a-retrospective-study-of-63-patients
#8
A Hernández-Martín, L Noguera-Morel, B Bernardino-Cuesta, A Torrelo, M A Pérez-Martin, C Aparicio-López, C de Lucas-Collantes
BACKGROUND: Cyclosporine A (CSA) is an immunosuppressant agent widely used in severe atopic dermatitis (AD). However, experience in children is limited. OBJECTIVES: To assess the efficacy and adverse events of CSA therapy in children. METHODS: Retrospective study of children with severe AD treated with CSA between January 2009 and December 2015. RESULTS: Data from 63 patients were collected. Mean age at the beginning of treatment was 8...
November 29, 2016: Journal of the European Academy of Dermatology and Venereology: JEADV
https://www.readbyqxmd.com/read/27473542/homeopathic-therapy-in-pediatric-atopic-diseases-short-and-long-term-results
#9
Elio Rossi, Marco Picchi, Paola Bartoli, Marialessandra Panozzo, Chiara Cervino, Linda Nurra
AIM: To study the outcomes of atopic diseases in children treated with homeopathy at the Homeopathic Clinic of Lucca (Italy) and related long-term results after approximately an 8-year period. MATERIALS AND METHODS: Our data derive from an observational longitudinal study carried out on 857 pediatric patients who consecutive visited from 1998 to 2014. Children with atopic diseases were 325 (37.9%), 126 (39%) suffered from atopic dermatitis, 72 (22%) from allergic rhinitis, and 127 (39%) from asthma...
August 2016: Homeopathy: the Journal of the Faculty of Homeopathy
https://www.readbyqxmd.com/read/27134697/debates-in-allergy-medicine-specific-immunotherapy-in-children-with-atopic-dermatitis-the-con-view
#10
David N Ginsberg, Lawrence F Eichenfield
Atopic dermatitis (AD) is a common chronic skin condition in children that has a proven association with other atopic conditions and allergies. These associations, like the general pathophysiology of AD, are complex and not fully understood. While there is evidence for the efficacy of specific immunotherapy (SIT) in pediatric asthma and allergic rhinitis (AR), there is a lack of strong data to support its use in AD. IgE has been shown to be elevated in many patients with AD, but it is an unreliable biomarker due to variability and great fluctuation over time, poor positive predictive value for clinically relevant allergy, and poor correlation with disease state...
2016: World Allergy Organization Journal
https://www.readbyqxmd.com/read/27075216/potential-preventive-effects-of-proactive-therapy-on-sensitization-in-moderate-to-severe-childhood-atopic-dermatitis-a-randomized-investigator-blinded-controlled-study
#11
RANDOMIZED CONTROLLED TRIAL
Tatsuki Fukuie, Satoshi Hirakawa, Masami Narita, Ichiro Nomura, Kenji Matsumoto, Yoshiki Tokura, Yukihiro Ohya
Proactive therapy for atopic dermatitis (AD) effectively prevents exacerbation. However, its role in preventing subsequent sensitization to allergens has not been prospectively studied. We investigated whether proactive therapy for AD can effectively impact immunological parameters in a randomized, investigator-blinded, parallel group study. Thirty patients aged 3 months to 7 years with moderate to severe AD who had undergone an AD educational program were allocated to a proactive treatment group or a reactive treatment group...
November 2016: Journal of Dermatology
https://www.readbyqxmd.com/read/26847292/retrospective-analysis-on-the-effects-of-house-dust-mite-specific-immunotherapy-for-more-than-3-years-in-atopic-dermatitis
#12
Jungsoo Lee, Hemin Lee, Seongmin Noh, Byung Gi Bae, Jung U Shin, Chang Ook Park, Kwang Hoon Lee
PURPOSE: In extrinsic atopic dermatitis (AD), house dust mites (HDM) play a role in eliciting or aggravating allergic lesions. The nature of skin inflammation in AD has raised a growing interest in allergen-specific immunotherapy (SIT). Thus, we assessed clinical improvement and laboratory parameters for evaluation of the benefit of long-term SIT. MATERIALS AND METHODS: A total of 217 AD patients who were treated with SIT for at least 3 years were retrospectively assessed, by using their investigator global assessment, pruritus scores, loss of sleep (LOS), total serum IgE, and eosinophil counts collected...
March 2016: Yonsei Medical Journal
https://www.readbyqxmd.com/read/26804943/efficacy-of-proactive-long-term-maintenance-therapy-of-canine-atopic-dermatitis-with-0-0584-hydrocortisone-aceponate-spray-a-double-blind-placebo-controlled-pilot-study
#13
RANDOMIZED CONTROLLED TRIAL
Ana M Lourenço, Vanessa Schmidt, Berta São Braz, Diana Nóbrega, Telmo Nunes, José H Duarte-Correia, Daniela Matias, Emi Maruhashi, Christophe A Rème, Tim Nuttall
BACKGROUND: Long-term remission between flares of canine atopic dermatitis (CAD) can be difficult to achieve. Therefore, additional strategic forms of treatment are needed in order to target flare prevention. The concept of proactive therapy is recommended in the European guidelines for the treatment of human atopic eczema. OBJECTIVES: To evaluate the efficacy of a proactive treatment regimen with a 0.0584% hydrocortisone aceponate (HCA) spray for CAD. ANIMALS: Client-owned dogs with spontaneous atopic dermatitis (AD) (n = 41)...
April 2016: Veterinary Dermatology
https://www.readbyqxmd.com/read/26377142/atopic-dermatitis
#14
REVIEW
Stephan Weidinger, Natalija Novak
Atopic dermatitis (also known as atopic eczema) is a chronic inflammatory skin disease that is characterised by intense itching and recurrent eczematous lesions. Although it most often starts in infancy and affects two of ten children, it is also highly prevalent in adults. It is the leading non-fatal health burden attributable to skin diseases, inflicts a substantial psychosocial burden on patients and their relatives, and increases the risk of food allergy, asthma, allergic rhinitis, other immune-mediated inflammatory diseases, and mental health disorders...
March 12, 2016: Lancet
https://www.readbyqxmd.com/read/26336506/atopic-allergy-and-chronic-inflammation-of-the-oral-mucosa-in-a-3-year-old-boy-after-heart-transplantation-diagnostic-and-therapeutic-difficulties
#15
Edyta Machura, Beata Chodór, Magdalena Kleszyk, Małgorzata Pindycka-Piaszczyńska, Ewelina Chrobak, Jacek Białkowski
In recent years, we have been observing an increased proportion of atopic diseases in children after solid organ transplantation. The pathogenesis of post-transplantation allergy is not completely understood and probably involves several factors, including immunosuppressive therapy. In this paper we present a case of 3-year old boy, after orthotopic heart transplantation at 6 months of age, with symptoms of food allergy associated with atopic dermatitis and changes in the orofacial area. The mentioned symptoms and elevated levels of total and specific IgE occurred with a year of transplant...
June 2015: Kardiochirurgia i Torakochirurgia Polska, Polish Journal of Cardio-Thoracic Surgery
https://www.readbyqxmd.com/read/26273148/personalized-immunomodulatory-therapy-for-atopic-dermatitis-an-allergist-s-view
#16
REVIEW
Dong-Ho Nahm
The current standard medical therapy for atopic dermatitis (AD) mainly focuses on symptomatic relief by controlling skin inflammation with topical corticosteroids and/or topical calcineurin inhibitors. However, the clinical efficacy of pharmacological therapy is often disappointing to both patients and physicians. The terminology of AD contains a historical meaning of eczematous dermatitis caused by hypersensitivity reaction to environmental inhalant or food allergen. Complex interrelationships among genetic abnormalities, environmental triggers, skin barrier defects, and immune dysfunction resulting in a vicious domino-circle seem to be involved in the development and maintenance of AD...
August 2015: Annals of Dermatology
https://www.readbyqxmd.com/read/26080926/atopic-dermatitis-drug-delivery-approaches-in-disease-management
#17
REVIEW
Manisha Lalan, Jitendra Baweja, Ambikanandan Misra
In this review, we describe the very basic of atopic dermatitis (AD), the established management strategies, and the advances in drug delivery approaches for successful therapeutic outcomes. The multifactorial pathophysiology of AD has given rise to the clinician's paradigm of topical and systemic therapy and potential combinations. However, incomplete remission of skin disorders like AD is a major challenge to be overcome. Recurrence is thought to be due to genetic and immunological etiologies and shortcomings in drug delivery...
2015: Critical Reviews in Therapeutic Drug Carrier Systems
https://www.readbyqxmd.com/read/25444256/use-of-emollients-in-atopic-dermatitis
#18
REVIEW
J P X Ng, H M Liew, S B Ang
Atopic dermatitis (AD) is a common inflammatory skin disorder that has strong financial and psychosocial impacts. Its pathogenesis is related to increased transepidermal water loss due to a defective skin epidermal barrier. Emollients serve as first-line therapy during both acute flares and remission. However, their use is poorly characterized, posing therapeutic challenges to clinicians and patients. In this article, we review available evidence to provide recommendations, aiming to standardize and optimize the use of emollients in AD...
May 2015: Journal of the European Academy of Dermatology and Venereology: JEADV
https://www.readbyqxmd.com/read/25132957/systemic-fungal-infection-in-a-dog-a-unique-case-in-ireland
#19
Sabela Atencia, Stratos Papakonstantinou, Bernadette Leggett, Hester McAllister, Carmel T Mooney
A three year old male entire Staffordshire bull terrier was referred to University College Dublin Veterinary Hospital, with a two week history of fever, inflammation of the right hock, lameness on the right hindlimb, peripheral lymphadenopathy and gastrointestinal signs (vomiting and diarrhoea). For the preceding three months the dog had been treated for atopic dermatitis with oral ciclosporin (5 mg/kg, PO, q 24 hours). Cytological analysis of the affected lymph nodes demonstrated fungal-like organisms predominantly contained within macrophages...
2014: Irish Veterinary Journal
https://www.readbyqxmd.com/read/25059452/retrospective-review-of-relapse-after-systemic-cyclosporine-in-children-with-atopic-dermatitis
#20
REVIEW
Cathryn Sibbald, Elena Pope, Nhung Ho, Miriam Weinstein
Cyclosporine is a systemic therapy used for control of severe atopic dermatitis (AD) in children. Although traditionally recommended at a dose of 5 mg/kg/day for 6 months, a longer duration of treatment may be necessary to bring a child with active and severe disease into remission. There are few data on the short- and long-term effectiveness of longer courses of therapy. This was a retrospective chart review of children treated with cyclosporine at a Canadian hospital-affiliated clinic between 2000 and 2013...
January 2015: Pediatric Dermatology
keyword
keyword
118034
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"